एम्‍स के बारे में

Dr. SWATI SHARMA

डॉ. स्वाति शर्मा 

Present position:Scientistवैज्ञानिक

Department of Pharmacologyभेषजगुणविज्ञानविभाग,   

AIIMS, New Delhi-110029 अ. भ. आ. सं., नईदिल्ली-110029

Contact Details: Room No. 4019, 4^th Floor, Department of Pharmacology,

Teaching Block, All India Institute of Medical Sciences (AIIMS), New Delhi 110029

Telephone: 011-26593677, 26589391

Mobile No. 9873730885

Email ID:  यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए. ; यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

Education: M.Sc. (Biotechnology), Ph. D.

Research Interest/ area:

Major: Metal toxicology, Pharmacogenomics & Bioinformatics, Poisoning awareness

Other Specializations: Technology Foresight and assessment in the areas of Medical Sciences & Health Care; Biotechnology & allied areas of Life Sciences and Climate Change.

Past Position: Scientist-B (Dec. 20, 2010- March 28, 2019)

Technology Information, Forecasting and Assessment Council (TIFAC), Department of Science and Technology, Govt. of India, New Delhi.

Involved in:

1. NATIONAL LEVEL TECHNOLOGY VISION 2035 EXERCISE

            a)  National Document- “Technology Vision 2035” released by Hon’ble Prime Minister on 3^rd Jan. 2016. 

            b) “Technology Roadmap of “Medical Sciences & Health Care: Technology Vision 2035” released by Dr. Y. S. Chowdhary, Hon’ble Minister of                      Science & Technology on 29th Sept., 2016.

1. TECHNOLOGY NEEDS ASSESSMENT- CLIMATE CHANGE PROJECT

            Biennial Update Reports (BURs: BUR-I & II) and Technology Needs Assessment for Climate Changein Health sector.

Achievements  

Author in Chapter of National Documents  

1. Core team member of National level “Technology Vision 2035” Document. 

2. Chapter on “Health Awareness” in Technology Roadmap on Medical Sciences & Health Care sector, 2016. 

3. HEALTH SCENARIOS: Future of Medical Sciences and Healthcare, 2016. 

4. Chapter on “Finance, Technology and Capacity Building Needs and Support Received: Technology needs and support received” India Second Biennial Update Report (BUR-II) to the United Nations Framework Convention on Climate Change (UNFCC). 

Important Publications  

1. Sharma S, Gurudutta GU and Singh U. Regulation of Hematopoietic Activity Involving New Interacting Partners (RRAGC & PSMC2, CKAP4 & MANF and CTR9 & CNTNAP2). CellBio, 9(3), 123-141. https://doi.org/10.4236/cellbio.2020.93007. 

2. Sharma S, Gurudutta GU and Singh U. Stem Cells Origins of Cytokine Interactions. Series: Stem Cells – Laboratory and Clinical Research. 2019. Chapter-16. 

3. Sharma S, Gurudutta GU and Singh U. Analysis of Signal Networks in Hematopoietic Stem Cells determining the stem cell fate. European Journal of Pharmaceutical & Medical Research (EJPMR). 2018;5(1):391-398. 

4. Sharma S, Gurudutta GU and Singh U. Stem Cell genes synergism: Elucidation of the mechanistic basis of response induced by cytokine combination (IL-3, FLT-3 and SCF). Journal of Stem Cells. 2017; 12(4):143-160. 

5. Sharma S. People’s Attitude towards Healthcare Technologies. International Journal of HealthCare & Medical Informatics 2017 (ISSN 2455–9199); 4(2): 24-27. Doi https://doi.org/10.24321/2455.9199.201710. 

6. Sharma S, Goswami G. A perspective on Medical Sciences & Healthcare. Healthy India Chronicle. July, 2017. 1(1): 66-71 www.healthyindiachronicle.in. 

7. Sharma S, Jancy A & Kishore J. Technology Driven Healthcare; Advanced Techniques in Biology & Medicine (ISSN 2379-1764); 3 (3), Nov. 2015. doi 10.4172/2379-1764. 

8. Sharma S& Kishore J. Priority issues in adolescent health; Indian Journal of Youth & Adolescent Health. 2014(ISSN 2349-2880); 1(2): 34-47. 

9. Sharma S. Stem Cells Niche- A Complex Molecular Milieu; International Journal of Pharmaceutical and Biological Science Archive (ISSN 2230-7605); 1 (3) 2013, 06-08. 

10. Sharma S. Information Based Medicine: An approach towards individualized healthcare; pharmatutor 2013 (may be cited at www.pharmatutor.org). 

DR. AMITA SRIVASTAVA

Scientist

Department of Pharmacology,

All India Institute of Medical Sciences (AIIMS), New Delhi  

Telephone:  011-26548560

Mobile No. 9868457844

Email ID:  यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए. ; यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

Education

M.Sc. & Ph.D.  

Research Interest/ area

Toxicology & Poisoning, Metal Toxicology, Neuro- pharmacology  

Awards/ Achievements  

1. Received IAMLE fellowship in 10^th International conference on Indian Association of Medico legal experts (IAMLE) & Medico-Legal Conference, in recognition of outstanding contribution and service, in the field of Forensic Chemistry & Toxicology on 12^th September 2019 at Nepal, Kathmandu.
2. Awarded first prize in oral presentation entitled  Determination of Metals by Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES)” in Forensic Toxicology, Pharmacology & Miscellaneous session in Indian Association of Medico legal Experts in the 9^th International Conference on Legal Medicine Medical Negligence and Litigation in Medical practice & 9^th International Conference on current Trends in Forensic Sciences, Forensic Medical & Toxicology on 26^th -28^th October IAMLE 2018 at Pune.

Chapter in Manual and Books  

1. Kumar G, Srivastava A, Singh V. Estimation of metals by Inductively Coupled Plasma- Atomic Emission Spectrophotometer (ICP-AES). Research methodologies in Basic & clinical Pharmacology 2008: 28-36.  
2. Srivastava A, Kumar G, Shastri K. Estimation of heavy metals by atomic absorption spectrophotometer. Research methodologies in Basic clinical Pharmacology 2008: 1-10. 
3. Gupta SK, Srivastava A, Kaleekal T and Peshin SS. Management of Commonly Encountered Drug Poisonings, Pharmacological Perspectives of Toxic Chemicals and their Antidotes. Narosa Publishing Copyright New Delhi © 2004: 395-410.  
4. Srivastava A. Mushroom and Food Poisoning, Emergency Toxicology, Management of Common Poisons. Narosa Publishing House, New Delhi. 2002: 137-142.  
5. Srivastava A. Household products, Emergency Toxicology, Management of Common Poisons. Narosa Publishing House, New Delhi. 2002: 78-99.  
6. Srivastava A. Herbicides and Fungicides, Emergency Toxicology, Management of Common Poisons. Narosa Publishing House, New Delhi. 2002:52-69.  
7. Srivastava A. & Lall SB. Ticks & Mites, Management of common Indian Snakes & Insect bites- Copyright (C) 1997.

Important Publications  

1. Kalsi AK, Halder A, Jain M, Srivastava A. Association of Cadmium, Chromium, Manganese and Lead with Hyperprolactinemia: A Pilot Study. Journal of Clinical and Diagnostic Research. 2020;14(1): QC04-QC07.  
2. Sehgal R, GulatIi S, Gupta YK, Sapra S, Mehta M, Pandey RM, Kumar G, Srivastava A and Kabra M. Blood heavy metal levels in children with Autism Spectrum Disorder: A cross sectional study from Northern India. J Nepal Paediatr Soc. 2019;39(1):6-14.  
3. Jain M, kalsi AK, Srivastava A, Gupta YK. High serum estradiol and heavy metals responsible for human spermination defect- A pilot study. Journal of Clinical and Diagnostic Research. 2016; 10(12): RC09-RC13.  
4. Naz F, Koul V, Srivastava A, Gupta YK, Dinda AK. Biokinetics of ultrafine gold nanoparticles (AuNPs) relating to redistribution and urinary excretion: a long-term in vivo study. J Drug Target. 2016; 24(8): 720-29.  
5. Kumar G, Srivastava A, Sharma SK, Gupta YK. Efficacy and safety evaluation   of Ayurvedic treatment (Ashwagandha powder and Sidh Makardhwaj) in rheumatoid     arthritis patients: a pilot prospective cohort clinical study. Indian J Med Res. 2015; 141: 100-6.  
6. Peshin SS, Srivastava A, Gupta YK. Poisoning in children: a helpline experience. J  Clin Toxicol2014; 4: 51.  
7. Srivastava A, Peshin SS, Gupta YK. Snake bite poisoning: poisoning: A twelve year retrospective analysis of the poisoning calls reported to the National Poisons Information Centre at AIIMS. J Clin Toxicol. 2014; 4: 105.  
8. Peshin SS, Srivastava A, Halder N, Gupta YK. Pesticide poisoning trend analysis of 13 years: A retrospective study based on telephone calls at the National Poisons Information Centre, All India Institute of Medical Sciences, New Delhi. Journal of Forensic and Legal Medicine. 2014;22: 57-61.  
9. Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety evaluation of mercury based Ayurvedic formulation (Sidh Makardhwaj) on brain cerebrum, liver & kidney in rats.   Indian J Med Res. 2014; 139 (4): 610-8.  
10. Kumar G, Srivastava A, Sharma SK, Gupta YK. The hypolipidemic activity of Ayurvedic medicine, Arogyavardhani vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with Fenofibrate. Journal of Ayurvedic & Integrated Medicine. 2013; 4: 165-70.  
11. Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety and efficacy evaluation of     Ayurvedic treatment (Arjuna powder and Arogyvardhanivati) in dyslipidaemia patient: a pilot prospective cohort clinical study. Ayu. 2012; 33(2): 197-201.  
12. Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety evaluation of an ayurvedic medicine, Arogyvardhinivati on brain, liver and kindey in rats. Ethnopharmacol. 2012;140: 151-60.  
13. Srivastava A, Peshin SS, Kaleekal T. An epidemiological study of poisoning cases reported to the National Poisons Information Centre, All India Institute of Medical Sciences, New Delhi. Human & Experimental Toxicology. 2005; 24: 279-85.